National Vision Inc. (EYE)
NASDAQ: EYE
· Real-Time Price · USD
18.62
-0.76 (-3.92%)
At close: May 21, 2025, 3:59 PM
18.55
-0.38%
After-hours: May 21, 2025, 06:42 PM EDT
National Vision Revenue Breakdown
| Period Ending | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Jan 2, 2021 | Dec 28, 2019 | Dec 29, 2018 | Dec 30, 2017 |
|---|---|---|---|---|---|---|---|---|
| Accessories And Other Revenue | 10.1M | 8.2M | 1.65B | 1.72B | 1.42B | 1.43B | 267.24M | 7.24M |
| Accessories And Other Revenue Growth | +23.17% | -99.50% | -4.08% | +21.16% | -0.55% | +433.65% | +3592.72% | n/a |
| Contact Lenses Revenue | 307.31M | 543.41M | 357.09M | 361.18M | 293.48M | 298.19M | 1.27B | 358.81M |
| Contact Lenses Revenue Growth | -43.45% | +52.18% | -1.13% | +23.07% | -1.58% | -76.51% | +253.84% | n/a |
| Eyeglasses And Sunglasses Revenue | 1.15B | 1.19B | n/a | n/a | n/a | n/a | n/a | 763.27M |
| Eyeglasses And Sunglasses Revenue Growth | -3.92% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Sales Revenue | 1.46B | 1.74B | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Sales Revenue Growth | -16.11% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Services And Plans Revenue | 360.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Services And Plans Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Jan 2, 2021 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 2, 2016 | Apr 2, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 255.53M | 233.05M | 233.99M | 231.69M | 244.78M | 249.17M | 249.71M | 243.97M | 249.92M | 233.94M | 225.03M | 227.83M | 228.55M | 224.76M | 218.21M | 234.24M | 223.59M | 199.75M | 190.52M | 136.58M | 193.74M | 178.04M | 190.29M | 182.28M | 193.88M | 166.13M | 184.42M | 165.04M | 170.1M | 152.21M | 151.25M | 144.66M | 149.8M | 128.85M | 134.46M | 130.46M | 130.46M |
| Selling, General, and Administrative Revenue Growth | +9.65% | -0.40% | +0.99% | -5.35% | -1.76% | -0.22% | +2.35% | -2.38% | +6.83% | +3.96% | -1.23% | -0.32% | +1.69% | +3.00% | -6.84% | +4.76% | +11.94% | +4.85% | +39.49% | -29.50% | +8.82% | -6.44% | +4.40% | -5.98% | +16.70% | -9.92% | +11.75% | -2.98% | +11.75% | +0.63% | +4.56% | -3.44% | +16.26% | -4.17% | +3.06% | 0.00% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |